Alexis Whitton

Dr. Alexis Whitton


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Current Opinion in Psychiatry
Verified
Journal Article
Closed access
AWAlexis Whitton
Alexis Whitton
MTMichael T. Treadway
Michael T. Treadway
DPDiego A. Pizzagalli
Diego A. Pizzagalli
Purpose of review This article reviews the recent literature on reward processing dysfunction in major depression (MDD), bipolar disorder and schizophrenia, with a focus on approach motivation, reward learning and reward-based decision-making. Recent findings Emerging evidence indicates the presence of reward processing abnormalities across all three disorders, supporting a transdiagnostic approach. In particular, findings are consistent with a role of abnormal phasic striatal dopamine signaling, which is critical for reinforcement learning, efficient mobilization of effort to obtain reward and allocation of attention to reward-predictive cues. Specifically, reward-related striatal signaling appears blunted in MDD and the negative symptoms of schizophrenia, elevated in bipolar (hypo)mania, and contextually misallocated in the positive symptoms of psychosis. However, whether shared or distinct pathophysiological mechanisms contribute to abnormal striatal signaling across the three disorders remains unknown. Summary New evidence of reward processing abnormalities in MDD, bipolar disorder and schizophrenia has led to a greater understanding of the neural processes associated with symptomatology common across these conditions (e.g., anhedonia). Dissecting various subcomponents of reward processing that map onto partially different neurobiological pathways and investigating their dysregulation in different psychiatric disorders holds promise for developing more targeted, and hopefully efficacious treatment and intervention strategies.

18 November 2013 in BMC Psychiatry
Verified
Journal Article
Open access
PDF file
JPJudith Proudfoot
Judith Proudfoot
JCJanine Clarke
Janine Clarke
MBMary-Rose Birch
Mary-Rose Birch
AWAlexis Whitton
Alexis Whitton
GPGordon Parker
Gordon Parker
DHDusan Hadzi-Pavlovic
Dusan Hadzi-Pavlovic
Mobile phone-based psychological interventions enable real time self-monitoring and self-management, and large-scale dissemination. However, few studies have focussed on mild-to-moderate symptoms where public health need is greatest, and none have targeted work and social functioning. This study reports outcomes of a CONSORT-compliant randomised controlled trial (RCT) to evaluate the efficacy of myCompass, a self-guided psychological treatment delivered via mobile phone and computer, designed to reduce mild-to-moderate depression, anxiety and stress, and improve work and social functioning. Community-based volunteers with mild-to-moderate depression, anxiety and/or stress (N = 720) were randomly assigned to the myCompass program, an attention control intervention, or to a waitlist condition for seven weeks. The interventions were fully automated, without any human input or guidance. Participants’ symptoms and functioning were assessed at baseline, post-intervention and 3-month follow-up, using the Depression, Anxiety and Stress Scale and the Work and Social Adjustment Scale. Retention rates at post-intervention and follow-up for the study sample were 72.1% (n = 449) and 48.6% (n = 350) respectively. The myCompass group showed significantly greater improvement in symptoms of depression, anxiety and stress and in work and social functioning relative to both control conditions at the end of the 7-week intervention phase (between-group effect sizes ranged from d = .22 to d = .55 based on the observed means). Symptom scores remained at near normal levels at 3-month follow-up. Participants in the attention control condition showed gradual symptom improvement during the post-intervention phase and their scores did not differ from the myCompass group at 3-month follow-up. The myCompass program is an effective public health program, facilitating rapid improvements in symptoms and in work and social functioning for individuals with mild-to-moderate mental health problems. Australian New Zealand Clinical Trials Registry ACTRN 12610000625077

19 December 2010 in Journal of Medical Internet Research
Verified
Journal Article
Open access
JPJudith G Proudfoot
Judith G Proudfoot
GPGordon B Parker
Gordon B Parker
DPDusan Hadzi Pavlovic
Dusan Hadzi Pavlovic
VMVijaya Manicavasagar
Vijaya Manicavasagar
EAEinat Adler
Einat Adler
AWAlexis Whitton
Alexis Whitton
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet

30 March 2020 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
AKAndrew D. Krystal
Andrew D. Krystal
DPDiego A. Pizzagalli
Diego A. Pizzagalli
MSMoria Smoski
Moria Smoski
SMSanjay J. Mathew
Sanjay J. Mathew
JNJohn Nurnberger
John Nurnberger
WPWilliam Z. Potter
William Z. Potter

26 June 2020 in Neuropsychopharmacology
Verified
Journal Article
Closed access
PDF file
MMMichael Murphy
Michael Murphy
AWAlexis Whitton
Alexis Whitton
SDStephanie Deccy
Stephanie Deccy
MIManon L. Ironside
Manon L. Ironside
ARAshleigh Rutherford
Ashleigh Rutherford
DPDiego A. Pizzagalli
Diego A. Pizzagalli

1 December 2012 in Journal of Affective Disorders
Verified
Journal Article
Closed access
JPJudith Proudfoot
Judith Proudfoot
GPGordon Parker
Gordon Parker
VMVijaya Manicavasagar
Vijaya Manicavasagar
DHDusan Hadzi-Pavlovic
Dusan Hadzi-Pavlovic
AWAlexis Whitton
Alexis Whitton
RBRowan Burckhardt
Rowan Burckhardt